25 May 2013
Keywords: bayer/regeneron, vegf, trap, cuts, retina, thickness, germany
Article | 02 April 2007
Germany's Bayer HealthCare AG and USA-based Regeneron reported positive preliminary data from a pre-planned interim analysis of a Phase II
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 April 2007
26 March 2007
24 May 2013
© 2013 thepharmaletter.com